IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2503-2509

  Ruth, Jeffrey H ^a,b   Bienkowski, Michael ^c   Warmington, Kelly S ^a   Lincoln, Pamela M ^b   Kunkel, Steven L ^b   Chensue, Stephen W ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION; GENETIC REGULATION; GRANULOMA; IMMUNE RESPONSE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, HELMINTH; CYTOKINES; FEMALE; GRANULOMA; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LYMPH NODES; MACROPHAGES; MICE; MICE, INBRED CBA; MYCOBACTERIUM TUBERCULOSIS; RABBITS; RECEPTORS, INTERLEUKIN-1; SCHISTOSOMA MANSONI; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029881638     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Eisenberg, S. P., R. J. Evens, W. P. Arend, E. Verderberr, M. T. Brewer, C. H. Hannum, and R. C. Thompson. 1990. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341.
2. Hannum, C. H., C. J. Wilcox, W. P. Arend, F. G. Joslin, D. J. Dripps, P. L. Heimdal, L. G. Armes, A. Sommer, S. P. Eisenberg, and R. C. Thompson. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336.
3. Seckinger, P., J. W. Lowenthal, K. Williamson, J.-M. Dayer, and H. R. MacDonald. 1987. A urine inhibitor of interleukin-1 activity that blocks ligand binding. J. Immunol. 139:1546.
4. Prieur, A. M., M-T. Kaufmann, C. Griscelli, and J.-M. Dayer. 1987. Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis. Lancet 2:1220.
5. Firestein, G. S., A. E. Berger, D. L. Chapman, D. E. Tracey, J. G. Chosay, and N. J. Zvaifler. 1991. IL-1 receptor antagonist protein (IRAP) production and gene expression by rheumatoid arthritis (RA) and osteoarthritis (OA) synovium. Clin. Res. 39:291A.
6. Haskill, S., G. Martin, L. Van Le, J. Morris, A. Peace, C. F. Bigler, G. J. Jaffe, C. Hammerberg, S. A. Sporn, S. Fong, W. P. Arend, and P. Ralph. 1991. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc. Natl. Acad. Sci. USA 88:3681.
7. Ohlsson, K., P. Bjork, M. Bergenfeldt, R. Hageman, and R. C. Thompson. 1990. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550.
8. Wakabayashi, G., J. A. Gelfand, J. F. Burke, R. C. Thompson, and C. A. Dinarello. 1991. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 5:338.
9. Fischer, E., M. A. Marano, K. J. Van Zee, C. S. Rock, A. S. Hawes, W. A. Thompson, L. DeForge, J. S. Kenney, D. G. Remick, D. C. Bloedow, R. C. Thompson, S. F. Lowry, and L. L. Moldawer. 1992. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J. Clin. Invest. 89:1551.
10. Alexander, H. R., G. M. Doherty, C. M. Buresh, D. J. Venzon, and J. A. Norton. 1991. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173:1029.
11. Cominelli, F., C. C. Nast, B. D. Clark, R. Schindler, R. Lierena, V. E. Eysselein, R. C. Thompson, and C. A. Dinarello. 1990. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J. Clin. Invest. 86:972.
12. Schwab, J. H., S. K. Anderle, R. R. Brown, F. G. Dalldorf, and R. C. Thompson. 1991. Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect. Immun. 59:4436.
13. Dayer-Metroz, M. D., C. B. Wollheim, P. Seckinger, and J. M. Dayer. 1989. A natural interleukin 1 (BL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets. J. Autoimmun. 2:163.
14. Chensue, S. W., M. Bienkowski, T. E. Eessalu, K. S. Warmington, S. D. Hershey, N. W. Lukacs, and S. L. Kunkel. 1993. Endogenous IL-1 receptor antagonist protein (IRAP) regulates schistosome egg granuloma formation and the regional lymphoid response. J. Immunol. 151:3654.
15. Orino, E., S. Sone, A. NII, and T. Ogura. 1992. EL-4 up-regulates IL-1 receptor antagonist gene expression and its production in human blood monocytes. J. Immunol. 149:925.
16. Fenton, M. J., J. A. Buras, and R. P. Donnelly. 1992. IL-4 reciprocally regulates DL-1 and IL-1 receptor antagonist expression in human monocytes. J. Immunol. 149:1283.
17. Berger, A. E., D. B. Carter, S. O. Hankey, and R. N. McEwan. 1993. Cytokine regulation of the interleukin-1 receptor antagonist protein in U937 cells. Eur. J. Immunol. 23:39.
18. Allen, J. B., H. L. Wong, G. L. Costa, M. J. Bienkowski, and S. M. Wahl. 1993. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by EL-4 contribute to resolution of experimental arthritis. J. Immunol. 151:4344.
19. Wong, H. L., G. L. Costa, M. T. Lotze, and S. M. Wahl. 1993. Interleukin 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo. J. Exp. Med. 177:775.
20. Vannier, E., L. C. Miller, and C. A. Dinarello. 1992. Coordinated anti-inflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA 89:4076.
21. Chensue, S. W., K. S. Warmington, A. E. Berger, and D. E. Tracey. 1992. Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas. Am. J. Pathol. 140: 269.
22. Tilg, H., J. W. Mier, W. Vogel, W. E. Aulitzky, C. J. Wiedermann, E. Vannier, C. Huber, and C. A. Dinarello. 1993. Induction of circulating IL-1 receptor antagonist by IFN treatment. J. Immunol. 150:4687.
23. Chensue, S. W., K. S. Warmington, J. Ruth, P. Lincoln, M. Kuo, and S. L. Kunkel. 1994. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation, production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am. J. Pathol. 145:1105.
24. Schuck, M., T. Eessalu, D. Tracey, and M. Bienkowski. 1992. Cloning, heterologous expression, and characterization of murine IL-1 receptor antagonist protein. Eur. J. Immunol. 21:2775.
25. Hu-Li, J., C. Ohara, C. Watyson, W. Wang, and W. E. Paul. 1989. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 responsive mutant of that line (CT.4S). J. Immunol. 142:800.
26. Florentine, D. F., A. Zlotnick, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
27. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon-γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
28. Chensue, S. W., D. G. Remick, C. Shmyr-Forsch, T. F. Beals, and S. L. Kunkel. 1988. Immunohistochemical demonstration of cytoplasmic and membrane-associated tumor necrosis factor in murine macrophages. Am. J. Pathol. 133:564.
29. Remick, D. G., R. M. Strieter, M. K. Eskandari, D. T. Nguyen, M. A. Genord, C. L. Roiford, and S. L. Kunkel. 1990. Role of tumor necrosis factor-α in lipopolysaccharide-induced pathologic alterations. Am. J. Pathol. 136:49.
30. Carter, D. B., M. R. Deibel, C. J. Dunn, C. C. Tomich, A. L. Laborde, J. L. Slightom, A. E. Berger, M. J. Bienkowski, F. F. Sun, R. N. McEwan, P. K. W. Harris, A. W. Yem, H. A. Waszak, J. G. Chosay, L. C. Sieu, M. M. Hardee, Zurcher-Neely, I. M. Reardon, R. L. Heinrikson, S. E. Truesdell, J. A. Shelly, T. E. Eessalu, B. M. Taylor, and D. E. Tracey. 1990. Purification, cloning, expression, and biologic characterization of an interleukin-1 receptor antagonist protein. Nature 344:633.
31. Chensue, S. W., I. G. Otterness, G. I. Higashi, C. S. Forsch, and S. L. Kunkel. 1989. Monokine production by hypersensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages: evidence for sequential production of IL-1 and tumor necrosis factor. J. Immunol. 142:1281.
32. Chensue, S. W., P. D. Terebuh, K. S. Warmington, S. D. Hershey, H. L. Evanoff, S. L. Kunkel, and G. I. Higashi. 1992. Role of IL-4 and IFN-γ in Schistosoma mansoni egg-induced hypersensitivity granuloma formation: orchestration, relative contribution, and relationship to macrophage function. J. Immunol. 148:900.
33. Chensue, S. W., S. L. Kunkel, S. Hershey, K. Warmington, and D. E. Tracey. 1992. Interleukin-1 antagonist protein (IRAP) abrogates foreign body but not hypersensitivity-type granulomas. FASEB J. 6:A1330.
34. Chensue, S. W., K. S. Warmington, J. Ruth, P. M. Lincoln, and S. L. Kunkel. 1994. Cross-regulatory role of γ-IFN, IL-4, and IL-10 in schistosome egg granuloma formation: in vivo regulation of Th activity and inflammation. Clin. Exp. Immunol. 98:395.
35. Collart, M. A., D. Belin, J. Vassalli, S. de Kossodo, and P. Vassalli. 1986. γ-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164:2113.
36. Chensue, S. W., K. S. Warmington, J. H. Ruth, P. M. Lincoln, and S. L. Kunkel. 1995. Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation: local and regional participation of γ-IFN, IL-10, and TNF. J. Immunol. 154:5969.